Tenzing Acquisition Corp.

announcedU=S+3/4WW=S@11.50
RVPHSEC EDGARCIK: 0001742927|Reviva Pharmaceuticals Holdings, Inc.•Biopharmaceuticals

Capital Structure & Economics

Trust Size$50,500,000
Unit Price$4.82
Warrant Coverage3/4
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

75% Warrant Inclusion
Public Trust Allocation$50,500,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$4.82
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedJul 20, 2018
SearchingTarget Pending
Maturation Wall
Aug 28, 2020

Announced Target / M&A

  • Target CompanyReviva Pharmaceuticals, Inc.
  • SectorBiopharmaceuticals
  • Announced Deal Size$62,400,000

Board & Officers

Advanced Structuring Terms

Target SectorsBiopharmaceuticals

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction